Highlights NovAccess Global Inc.

Equities

XSNX

US67001N1072

Market Closed - OTC Markets Other stock markets 20:39:40 15/05/2024 BST			5-day change	1st Jan Change
0.00529 ^USD	-11.83%		-3.64%	-73.63%

04-29	NovAccess Global Inc. announced that it has received $0.0265 million in funding from AJB Capital Investments LLC	CI
02-27	NovAccess Global Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

NovAccess Global Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	02-27	CI
NovAccess Global Inc. Reports Earnings Results for the Full Year Ended September 30, 2023	02-09	CI
NovAccess Global Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023	11/08/23	CI
NovAccess Global Inc. Partners with BCN Biosciences to Expand Immunotherapy Platform	27/07/23	CI
NovAccess Global Partners with CKN Ventures to Expand its New AI-driven Precision Medicine Division	16/06/23	CI
NovAccess Global Inc. Launches Precision Medicine Division Using AI, Big Data and Predictive Technologies to Accelerate Personalised Healthcare Therapies	01/06/23	CI
NovAccess Global Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023	15/05/23	CI
NovAccess Global Inc. Reports Earnings Results for the First Quarter Ended December 31, 2022	14/02/23	CI
NovAccess Global Inc. Reports Earnings Results for the Full Year Ended September 30, 2022	10/01/23	CI
NovAccess Global Inc. Receives FDA Approval of Orphan Drug Application for TLR-AD1	28/10/22	CI
NovAccess Global Receives FDA Approval of Orphan Drug Application for TLR-AD1	26/10/22	CI
NovAccess Global Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2022	15/08/22	CI
NovAccess Global Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2022	16/05/22	CI
NovAccess Global Inc. Reports Earnings Results for the First Quarter Ended December 31, 2021	18/02/22	CI
NovAccess Global Inc. Reports Earnings Results for the Full Year Ended September 30, 2021	13/01/22	CI
Novaccess Global Inc. enters into A Securities Purchase Agreement with Ajb Capital Investments, Llc	25/08/21	CI
Novaccess Global Inc. Reports Earnings Results for the Third Quarter Ended June 30, 2021	13/08/21	CI
Novaccess Global Inc. Reports Earnings Results for the Second Quarter Ended March 31, 2021	20/05/21	CI
Novaccess Global Inc. Reports Earnings Results for the Full Year Ended September 30, 2020	30/03/21	CI
XsunX, Inc. completed the acquisition of StemVax, LLC from Innovest Global, Inc. on September 8, 2020.	07/09/20	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights NovAccess Global Inc.

Equities

XSNX

US67001N1072

Highlights

Filters